Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Action inhibitors, blockers |
Mechanism PDE5A inhibitors(Phosphodiesterase 5A inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (03 May 2016), |
Regulation- |
Molecular FormulaC26H31ClN2O8S |
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N |
CAS Registry111470-99-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erectile Dysfunction | South Korea | 03 May 2016 | |
Hypertension | South Korea | 03 May 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erectile Dysfunction | Discovery | - | 01 Sep 2014 | |
Hypertension | Discovery | - | 01 Sep 2014 |